Top stories in health and medicine, September 10, 2014

From MedPage Today: Bone Drugs Work; Effects and Risks Vary. Treatments for osteoporosis vary widely in terms of risk-benefit profile. Red Carpet Paves Way to Research $$$. Viewers of Stand Up To Cancer’s (SU2C) fourth 1-hour live prime-time commercial-free program — telecast over more than 30 broadcast and cable networks Friday night — pledged more than $109 million, with about $82 million slated for translational cancer research projects in the U.S. and about $27 million for Canadian researchers. Polypills on FDA Docket: One Pill Panacea? Will fixed-dose polypills safely and effectively reduce the risk of heart attack and stroke as well as individual doses of the same medications? That is the question that the FDA addresses this week in back-to-back advisory committee reviews of two investigational polypills. Ebola Response: Slowed by a ‘Perfect Storm’ of Setbacks. The world was taken by surprise by the West Africa Ebola outbreak and has been scrambling ever since to catch up, with many setbacks and only a few bright spots in the picture Your patients are rating you online: How to respond. Manage your online reputation: A social media guide. Find out how.
Source: Kevin, M.D. - Medical Weblog - Category: Journals (General) Authors: Tags: News Endocrinology Infectious disease Source Type: blogs